| scholarly article | Q13442814 |
| P50 | author | Britta Engelhardt | Q43814115 |
| Robert Rottapel | Q51814787 | ||
| P2093 | author name string | Pooja Jain | |
| Caroline Coisne | |||
| Gaby Enzmann | |||
| P2860 | cites work | Beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity | Q30486061 |
| Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis | Q33382375 | ||
| Control of alpha4beta7 integrin expression and CD4 T cell homing by the beta1 integrin subunit | Q33670018 | ||
| Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE | Q82810101 | ||
| Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS. | Q34140567 | ||
| Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis | Q35829642 | ||
| p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis | Q35855614 | ||
| Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases | Q35946021 | ||
| Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels | Q36168394 | ||
| Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance | Q36367773 | ||
| Regulation of immune cell entry into the central nervous system | Q36636302 | ||
| Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis | Q36766158 | ||
| Dendritic cell behaviour in vivo: lessons learned from intravital two-photon microscopy. | Q37145830 | ||
| Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. | Q37151168 | ||
| Perivascular spaces and the two steps to neuroinflammation | Q37329042 | ||
| P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice | Q40400365 | ||
| Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. | Q40453661 | ||
| Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1. | Q43863938 | ||
| Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. | Q46007698 | ||
| CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. | Q46450925 | ||
| L-selectin function is required for beta 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo. | Q46901209 | ||
| Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis | Q47884689 | ||
| Detection of endothelial/lymphocyte interaction in spinal cord microvasculature by intravital videomicroscopy | Q48206326 | ||
| Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells | Q48660181 | ||
| Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion. | Q48829755 | ||
| Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab | Q48882820 | ||
| The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system | Q48932592 | ||
| Two subsets of dendritic cells are present in human cerebrospinal fluid | Q48974990 | ||
| Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. | Q49014751 | ||
| The blood-central nervous system barriers actively control immune cell entry into the central nervous system | Q49018946 | ||
| Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. | Q52049353 | ||
| CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. | Q53015646 | ||
| Endothelial, not hemodynamic, differences are responsible for preferential leukocyte rolling in rat mesenteric venules. | Q53028508 | ||
| Immune surveillance in multiple sclerosis patients treated with natalizumab. | Q54606407 | ||
| Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions | Q59070288 | ||
| The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells | Q60446151 | ||
| Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures | Q73119250 | ||
| Is the pial microvessel a good model for blood-brain barrier studies? | Q73535651 | ||
| E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice | Q80139592 | ||
| Cutting edge: CNS CD11c+ cells from mice with encephalomyelitis polarize Th17 cells and support CD25+CD4+ T cell-mediated immunosuppression, suggesting dual roles in the disease process | Q80358422 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| dendritic cell | Q506253 | ||
| blood–brain barrier | Q221694 | ||
| P304 | page(s) | 7196-7206 | |
| P577 | publication date | 2010-05-17 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis | |
| P478 | volume | 184 |
| Q37747214 | A Novel Cervical Spinal Cord Window Preparation Allows for Two-Photon Imaging of T-Cell Interactions with the Cervical Spinal Cord Microvasculature during Experimental Autoimmune Encephalomyelitis |
| Q27349006 | Analysis of behavior and trafficking of dendritic cells within the brain during toxoplasmic encephalitis |
| Q33758969 | Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity |
| Q37665608 | Blocking initial infiltration of pioneer CD8(+) T-cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice |
| Q38028845 | Brain dendritic cells: biology and pathology. |
| Q35185219 | CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression |
| Q91986386 | CD49d/CD29-integrin controls the accumulation of plasmacytoid dendritic cells into the CNS during neuroinflammation |
| Q30541389 | CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier |
| Q54253244 | Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis. |
| Q36553718 | Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease. |
| Q92533933 | Dendritic Cell Accumulation in the Gut and Central Nervous System Is Differentially Dependent on α4 Integrins |
| Q89285825 | Dendritic Cells as an Alternate Approach for Treatment of Neurodegenerative Disorders |
| Q30530989 | Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation |
| Q39021691 | Dendritic cell migration in health and disease |
| Q39020365 | Dendritic cells in central nervous system autoimmunity. |
| Q37585706 | Effect of morphine and SIV on dendritic cell trafficking into the central nervous system of rhesus macaques |
| Q90586145 | Effective effectors: How T cells access and infiltrate the central nervous system |
| Q48246147 | Expressions of some neurotrophins and neurotrophic cytokines at site of spinal cord injury in mice after vaccination with dendritic cells pulsed with homogenate proteins |
| Q47559577 | FDC:TFH Interactions within Cervical Lymph Nodes of SIV-Infected Rhesus Macaques |
| Q55279847 | Follicular Dendritic Cells of Lymph Nodes as Human Immunodeficiency Virus/Simian Immunodeficiency Virus Reservoirs and Insights on Cervical Lymph Node. |
| Q38040667 | Going against the tide--how encephalitogenic T cells breach the blood-brain barrier |
| Q24296902 | Hematopoietic lineage cell-specific protein 1 functions in concert with the Wiskott-Aldrich syndrome protein to promote podosome array organization and chemotaxis in dendritic cells |
| Q38256670 | Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models. |
| Q36684162 | Immunologic privilege in the central nervous system and the blood-brain barrier |
| Q36884649 | Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS. |
| Q93014204 | Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis |
| Q26822941 | Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease |
| Q22001136 | Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo |
| Q35748581 | Mechanisms of dendritic cell trafficking across the blood-brain barrier |
| Q88637204 | MicroRNA signature of central nervous system-infiltrating dendritic cells in an animal model of multiple sclerosis |
| Q27303465 | Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation |
| Q26776234 | Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes |
| Q35575009 | Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection |
| Q39048568 | Natalizumab treatment of multiple sclerosis: new insights |
| Q92518423 | On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system |
| Q39003384 | PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE. |
| Q26753208 | Post-translational modification-regulated leukocyte adhesion and migration |
| Q45226905 | Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth |
| Q38020964 | T-cell trafficking in the central nervous system |
| Q46697060 | The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin |
| Q28478729 | Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis |
| Q47859915 | To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis. |
| Q28071461 | Vascular, glial, and lymphatic immune gateways of the central nervous system |
Search more.